This is the authors' abstract. We don't add key points for this paper.
Background: Vigabatrin (VGB) is an approved non-traditional antiepileptic drug that has been revealed to have potential for treating brain tumors; however, its effect on ionic channels in glioma cells remains largely unclear. Methods: With the aid of patch-clamp technology, we investigated the effects of VGB on various ionic currents in the glioblastoma multiforme cell line 13-06-MG. Results: In cell-attached configuration, VGB concentration-dependently reduced the activity of intermediate-conductance Ca 2+ -activated K + (IK Ca ) channels, while DCEBIO (5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one) counteracted the VGB-induced inhibition of IK Ca channels. However, the activity of neither large-conductance Ca 2+ -activated (BK Ca ) nor inwardly rectifying K + (K IR ) channels were affected by the presence of VGB in human 13-06-MG cells. However, in the continued presence of VGB, the addition of GAL-021 or BaCl 2 effectively suppressed BK Ca and K IR channels. Conclusions: The inhibitory effect of VGB on IK Ca channels demonstrated in the current study could be an important underlying mechanism of VGB-induced antineoplastic ( e.g. , anti-glioma) actions.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hung et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: